Treatment of post-transplant lymphoproliferative disorder with rituximab and radiation in a patient with second renal allograft

被引：4

作者：

Molnar, I ^{[1
]}

Keung, YK ^{[1
]}

机构：

[1] Wake Forest Univ, Sch Med, Dept Internal Med, Winston Salem, NC 27109 USA

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2001年 / 16卷 / 10期

关键词：

D O I：

10.1093/ndt/16.10.2114

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：2114 / 2115

页数：2

共 12 条

[1]

ARMITAGE JM, 1991, J HEART LUNG TRANSPL, V10, P877

[2] Interferon-α treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants [J].

Davis, CL ;

Wood, BL ;

Sabath, DE ;

Joseph, JS ;

Stehman-Breen, C ;

Broudy, VC .

TRANSPLANTATION, 1998, 66 (12) :1770-1779

[3]

Glez-Chamorro A, 2000, HEPATO-GASTROENTEROL, V47, P211

[4] B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome [J].

Gross, TG ;

Steinbuch, M ;

DeFor, T ;

Shapiro, RS ;

McGlave, P ;

Ramsay, NKC ;

Wagner, JE ;

Filipovich, AH .

BONE MARROW TRANSPLANTATION, 1999, 23 (03) :251-258

[5]

HANTO DW, 1985, TRANSPLANT P, V17, P89

[6] Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: A distinct entity? [J].

Leblond, V ;

Davi, F ;

Charlotte, F ;

Dorent, R ;

Bitker, MO ;

Sutton, L ;

Gandjbakhch, I ;

Binet, JL ;

Raphael, M .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) :2052-2059

[7] Effective treatment of high-grade lymphoproliferative disorder after renal transplantation using autologous lymphocyte activated killer cell therapy [J].

Li, PKT ;

Tsang, K ;

Szeto, CC ;

Wong, TYH ;

To, KF ;

Leung, CB ;

Lui, SF ;

Yu, S ;

Lai, FMM .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :813-819

[8] Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients [J].

Milpied, N ;

Vasseur, B ;

Parquet, N ;

Garnier, JL ;

Antoine, C ;

Quartier, P ;

Carret, AS ;

Bouscary, D ;

Faye, A ;

Bourbigot, B ;

Reguerre, Y ;

Stoppa, AM ;

Bourquard, P ;

de Ligny, BH ;

Dubief, F ;

Mathieu-Boue, A ;

Leblond, V .

ANNALS OF ONCOLOGY, 2000, 11 :113-116

[9] Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients [J].

Nalesnik, MA ;

Rao, AS ;

Furukawa, H ;

Pham, S ;

Zeevi, A ;

Fung, JJ ;

Klein, G ;

Gritsch, HA ;

Elder, E ;

Whiteside, TL ;

Starzl, TE .

TRANSPLANTATION, 1997, 63 (09) :1200-1205

[10] Are post-transplant lymphomas inevitable? [J].

Opelz, G .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (10) :1952-1955

← 1 2 →